BIM-018
From Wikipedia, the free encyclopedia
Legal status | |
---|---|
Legal status |
|
Identifiers | |
|
|
ChemSpider | 29763750 |
Chemical and physical data | |
Formula | C23H22N2O |
Molar mass | 342.4 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
BIM-018 is a synthetic cannabinoid that is the benzimidazole analog of JWH-018. It is presumed to be a potent agonist of the CB2 receptor and has been sold online as a designer drug.[1]
Related benzimidazole derivatives have been reported to be highly selective agonists for the CB2 receptor.[2]
See also[edit]
References[edit]
- ^ "BIM-018". Cayman Chemical. Retrieved 24 July 2015.
- ^ Daniel Pagé; Elise Balaux; Luc Boisvert; Ziping Liu; Claire Milburn; Maxime Tremblay; Zhongyong Wei; Simon Woo; Xuehong Luo; Yun-Xing Cheng; Hua Yang; Sanjay Srivastava; Fei Zhou; William Brown; Miroslaw Tomaszewski; Christopher Walpole; Leila Hodzic; Stéphane St-Onge; Claude Godbout; Dominic Salois; Keymal Payza (July 2008). "Novel benzimidazole derivatives as selective CB2 agonists". Bioorganic & Medicinal Chemistry Letters. 18 (13): 3695–3700. doi:10.1016/j.bmcl.2008.05.073. PMID 18522867.
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |